Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

51.3K
Overview
51.3K
Development of Immunocompetence01:22

Development of Immunocompetence

795
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
795
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

3.6K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.6K
Preventive Healthcare Services01:30

Preventive Healthcare Services

1.9K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.9K
Prevalence and Incidence01:08

Prevalence and Incidence

1.5K
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.5K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

2.0K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retraction Note: Surface modification minimizes the toxicity of silver nanoparticles: an in vitro and in vivo study.

Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry·2026
Same author

Vaccine uptake in the context of mandate announcement and removal: Evidence from Europe and North America.

Vaccine·2026
Same author

Mpox disease epidemiology, vaccine uptake and vaccination coverage in Australia 2022-2024: a descriptive study.

EClinicalMedicine·2026
Same author

Annual immunisation coverage report 2024.

Communicable diseases intelligence (2018)·2026
Same author

ATAGI 2024 Annual Statement on Immunisation.

Communicable diseases intelligence (2018)·2026
Same author

ATAGI 2025 Annual Statement on Immunisation.

Communicable diseases intelligence (2018)·2026
Same journal

Measles epidemiology in Australia: 2014 to 2024. Erratum to 10.33321/cdi.2026.50.016.

Communicable diseases intelligence (2018)·2026
Same journal

Presymptomatic transmission, vaccine breakthrough and anonymous contacts: a cluster of mpox in Canberra, Australian Capital Territory, 2024.

Communicable diseases intelligence (2018)·2026
Same journal

The Strategic Plan for Tuberculosis Elimination and Equity in Australia 2026-2030.

Communicable diseases intelligence (2018)·2026
Same journal

An atlas of common Salmonella serotypes from routinely notified human cases in the Northern Territory of Australia, 2005-2024.

Communicable diseases intelligence (2018)·2026
Same journal

Meningococcal Surveillance Australia: Reporting period 1 October to 31 December 2025.

Communicable diseases intelligence (2018)·2026
Same journal

Australian Gonococcal Surveillance Program, 1 October to 31 December 2025.

Communicable diseases intelligence (2018)·2026
See all related articles

Related Experiment Video

Updated: Jan 18, 2026

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

9.2K

Annual Immunisation Coverage Report 2022.

Brynley Hull1, Alexandra Hendry2, Aditi Dey2

  • 1National Centre for Immunisation Research and Surveillance; The Children's Hospital at Westmead; The University of Sydney. brynley.hull@health.nsw.gov.au.

Communicable Diseases Intelligence (2018)
|September 9, 2025
PubMed
Summary
This summary is machine-generated.

Australian childhood vaccination coverage saw a slight decrease in 2022 due to COVID-19 pandemic impacts, with greater declines observed in Indigenous children. Adult vaccination rates increased, possibly due to improved reporting, but remain suboptimal, necessitating further research into barriers and uptake strategies.

Keywords:
Aboriginal and Torres Strait Islander vaccination coverageinfluenza vaccinationvaccination coveragevaccination timeliness

More Related Videos

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

3.8K
Assessing Respiratory Immune Responses to Haemophilus Influenzae
06:32

Assessing Respiratory Immune Responses to Haemophilus Influenzae

Published on: June 29, 2021

2.5K

Related Experiment Videos

Last Updated: Jan 18, 2026

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

9.2K
Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

3.8K
Assessing Respiratory Immune Responses to Haemophilus Influenzae
06:32

Assessing Respiratory Immune Responses to Haemophilus Influenzae

Published on: June 29, 2021

2.5K

Area of Science:

  • Immunology
  • Public Health
  • Epidemiology

Background:

  • Australian Immunisation Register (AIR) data from April 2023 provides insights into vaccination coverage for children, adolescents, and adults.
  • The report focuses on the 2022 calendar year and historical trends, with an emphasis on National Immunisation Program vaccines.

Purpose of the Study:

  • To provide a comprehensive analysis and interpretation of vaccination coverage data.
  • To inform evidence-based immunisation policy and program development in Australia.

Main Methods:

  • Analysis of Australian Immunisation Register (AIR) data.
  • Focus on vaccination coverage for children, adolescents, and adults in 2022.
  • Comparison with previous years to identify trends and pandemic impacts.

Main Results:

  • Childhood vaccination coverage decreased by 0.6-1.1 percentage points in 2022 compared to 2021, with larger drops in Indigenous children.
  • Adolescent human papillomavirus (HPV) and meningococcal ACWY vaccine coverage showed modest declines, with greater impacts on Indigenous adolescents.
  • Adult vaccination coverage, including for zoster, pneumococcal (13vPCV), and influenza vaccines, generally increased in 2022, potentially due to mandatory AIR reporting.

Conclusions:

  • Modest declines in childhood and adolescent vaccination coverage in 2022 were linked to COVID-19 pandemic effects, disproportionately affecting Indigenous populations.
  • Adult vaccination coverage increased but remains suboptimal, with mandatory reporting likely improving data accuracy.
  • Further research is needed to understand acceptance and access factors influencing vaccine uptake in children and adolescents.